Table S1.
Prevalence of helminth infections at posttreatment time points
Study group | N | Any spp., n (%) | Hookworm, n (%)† | A. lumbricoides, n (%)† | Trichuris trichiuria, n (%)‡ |
9 mo | |||||
Placebo | 227 | 191 (84.1) | 160 (70.5) | 76 (33.5) | 72 (31.7) |
Albendazole | 181 | 94 (51.9)** | 59 (32.6)** | 24 (13.3)** | 38 (21.0)** |
21 mo | |||||
Placebo | 215 | 171 (80.0) | 144 (67.0) | 52 (24.2) | 62 (28.8) |
Albendazole | 148 | 58 (39.2)** | 32 (21.6)** | 18 (12.2)** | 24 (16.2)** |
**P values were generated from the modeled data for combined effect of albendazole treatment over time and were significant (P < 0.001) for any helminth and for each of the species separately. N, total number per group; n, number of infected subjects.
Diagnosed by PCR.
Diagnosed by microscopy.